Novel Approaches in DNA Methylation Studies – MS-HRM Analysis and Electrochemistry

Authors: M. Bartošík ;  E. Ondroušková
Authors‘ workplace: Regionální centrum aplikované molekulární onkologie, Masarykův onkologický ústav, Brno
Published in: Klin Onkol 2016; 29(Supplementum 4): 64-71
Category: Review
doi: 10.14735/amko20164S64


Cytosine methylation in DNA is an epigenetic mechanism regulating gene expression and plays a vital role in cell differentiation or proliferation. Tumor cells often exhibit aberrant DNA methylation, e.g. hypermethylation of tumor suppressor gene promoters. New methods, capable of determining methylation status of specific DNA sequences, are thus being developed. Among them, MS-HRM (methylation-specific high resolution melting) and electrochemistry offer relatively inexpensive instrumentation, fast assay times and possibility of screening multiple samples/DNA regions simultaneously. MS-HRM is due to its sensitivity and simplicity an interesting alternative to already established techniques, including methylation-specific PCR or bisulfite sequencing. Electrochemistry, when combined with suitable electroactive labels and electrode surfaces, has been applied in several unique strategies for discrimination of cytosines and methylcytosines. Both techniques were successfully tested in analysis of DNA methylation within promoters of important tumor suppressor genes and could thus help in achieving more precise diagnostics and prognostics of cancer. Aberrant methylation of promoters has already been described in hundreds of genes associated with tumorigenesis and could serve as important biomarker if new methods applicable into clinical practice are sufficiently advanced.

Key words:
DNA methylation – 5-methylcytosine – HRM analysis – melting temperature – DNA duplex – electrochemistry – nucleic acid hybridization

This work was supported by MEYS – NPS I – LO1413.

The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study.

The Editorial Board declares that the manuscript met the ICMJE recommendation for biomedical papers.

6. 5. 2016

16. 5. 2016


1. Herman JG, Baylin SB. Mechanisms of disease: gene silencing in cancer in association with promoter hypermethylation. New Engl J Med 2003; 349 (21): 2042–2054.

2. Walsh CP, Chaillet JR, Bestor TH. Transcription of IAP endogenous retroviruses is constrained by cytosine methylation. Nat Genet 1998; 20 (2): 116–117.

3. Xu GL, Bestor TH, Bourchis D et al. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 1999; 402 (6758): 187–191.

4. Belinsky SA, Nikula KJ, Palmisano WA et al. Aberrant methylation of p16 (INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci U S A 1998; 95 (20): 11891–11896.

5. Esteller M, Silva JM, Dominguez G et al. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 2000; 92 (7): 564–569.

6. Hegi ME, Diserens A, Gorlia T et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. New Engl J Med 2005; 352 (10): 997–1003.

7. Esteller M, Corn PG, Urena JM et al. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. Cancer Res 1998; 58 (20): 4515–4518.

8. Sato Y, Yoshizato T, Shiraishi Y et al. Integrated molecular analysis of clear-cell renal cell carcinoma. Nat Genet 2013; 45 (8): 860–867. doi: 10.1038/ng.2699.

9. Suzuki H, Maruyama R, Yamamoto E et al. DNA methylation and microRNA dysregulation in cancer. Molecular Oncology 2012; 6 (6): 567–578. doi: 10.1016/j.molonc.2012.07.007.

10. Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene 2002; 21 (35): 5400–5413.

11. Hublarova P, Hrstka R, Rotterova P et al. Prediction of human papillomavirus 16 E6 gene expression and cervical intraepithelial neoplasia progression by methylation status. Int J Gynecol Cancer 2009; 19 (3): 321–325. doi: 10.1111/IGC.0b013e31819d8a5c.

12. Delpu Y, Cordelier P, Cho WC et al. DNA methylation and cancer diagnosis. Int J Mol Sci 2013; 14 (7): 15029–15058. doi: 10.3390/ijms140715029.

13. Ehrlich M, Gamasosa MA, Huang LH et al. Amount and distribution of 5-methylcytosine in human DNA from different types of tissues or cells. Nucleic Acids Res 1982; 10 (8): 2709–2721.

14. Badal V, Chuang LS, Tan EH et al. CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. J Virol 2003; 77 (11): 6227–6234.

15. Li E, Bestor TH, Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 1992; 69 (6): 915–926.

16. Bruce S, Hannula-Jouppi K, Lindgren CM et al. Restriction site-specific methylation studies of imprinted genes with quantitative real-time PCR. Clin Chem 2008; 54 (3): 491–499. doi: 10.1373/clinchem.2007.098491.

17. von Känel T, Huber AR. DNA methylation analysis. Swiss Med Wkly 2013; 143: w13799. doi: 10.4414/smw.2013. 13799.

18. Herman JG, Graff JR, Myohanen S et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996; 93 (18): 9821–9826.

19. Eads CA, Danenberg KD, Kawakami K et al. Methy Light: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000; 28 (8): e32.

20. Tost J, Gut IG. DNA methylation analysis by pyrosequencing. Nat Protoc 2007; 2 (9): 2265–2275.

21. Xiong ZG, Laird PW. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res 1997; 25 (12): 2532–2534.

22. Jacinto FV, Ballestar E, Esteller M. Methyl-DNA immunoprecipitation (MeDIP): hunting down the DNA methylome. Biotechniques 2008; 44 (1): 35–43.

23. Wittwer CT, Reed GH, Gundry CN et al. High-resolution genotyping by amplicon melting analysis using LCGreen. Clin Chem 2003; 49 (6): 853–860.

24. Montgomery JL, Sanford LN, Wittwer CT. High-resolution DNA melting analysis in clinical research and diag- nostics. Expert Rev Mol Diagn 2010; 10 (2): 219–240. doi: 10.1586/erm.09.84.

25. Wojdacz TK, Dobrovic A. Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation. Nucleic Acids Res 2007; 35 (6): E41.

26. Wojdacz TK, Hansen LL, Dobrovic A. A new approach to primer design for the control of PCR bias in methylation studies. BMC Res Notes 2008; 1 (1): 54. doi: 10.1186/1756-0500-1-54.

27. Snell C, Krypuy M, Wong EM et al. BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype. Breast Cancer Res 2008; 10 (1): R12. doi: 10.1186/bcr1858.

28. Liu W, Gong J, Hu J et al. Quantitative assessment of AKAP12 promoter methylation in human prostate cancer using methylation-sensitive high-resolution melting: correlation with gleason score. Urology 2011; 77 (4): 1006.e1–1006.e7. doi: 10.1016/j.urology.2010.12. 010.

29. Dimitrakopoulos L, Vorkas PA, Georgoulias V et al. A closed-tube methylation-sensitive high resolution melting assay (MS-HRMA) for the semi-quantitative determination of CST6 promoter methylation in clinical samples. BMC Cancer 2012; 12: 486–497. doi: 10.1186/1471-2407-12-486.

30. Mastoraki S, Chimonidou M, Dimitrakopoulos L et al. A rapid and accurate closed-tube methylation-sensitive high resolution melting analysis assay for the semi-quantitative determination of SOX17 promoter methylation in clinical samples. Clin Chim Acta 2015; 444: 303–309. doi: 10.1016/j.cca.2015.02.035.

31. Yang X, Dai W, Kwong DL et al. Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting. Int J Cancer 2015; 136 (4): E127–E135.

32. Liu W, Guan M, Su B et al. Rapid determination of AKAP12 promoter methylation levels in peripheral blood using methylation-sensitive high resolution melting (MS-HRM) analysis: application in colorectal cancer. Clin Chim Acta 2010; 411 (13–14): 940–946.

33. Xiao Z, Li B, Wang G et al. Validation of methylation-sensitive high-resolution melting (MS-HRM) for the detection of stool DNA methylation in colorectal neoplasms. Clin Chim Acta 2014; 431: 154–163. doi: 10.1016/j.cca.2014.01.044.

34. Qiu C, Zhi Y, Shen Y et al. High-resolution melting analysis of HPV-16 L1 gene methylation: a promising method for prognosing cervical cancer. Clin Biochem 2015; 48 (13–14): 855–859. doi: 10.1016/j.clinbiochem.2015.05.006.

35. Jacquin E, Baraquin A, Ramanah R et al. Methylation of human papillomavirus type 16 CpG sites at E2-binding site 1 (E2BS1), E2BS2, and the Sp1-binding site in cervical cancer samples as determined by high-resolution melting analysis-PCR. J Clin Microbiol 2013; 51 (10): 3207–3215. doi: 10.1128/JCM.01106-13.

36. Candiloro IL, Mikeska T, Hokland P et al. Rapid analysis of heterogeneously methylated DNA using digital methylation-sensitive high resolution melting: application to the CDKN2B (p15) gene. Epigenetics Chromatin 2008; 1 (1): 7. doi: 10.1186/1756-8935-1-7.

37. Palecek E, Tkac J, Bartosik M et al. Electrochemistry of nonconjugated proteins and glycoproteins. Toward sensors for biomedicine and glycomics. Chem Rev 2015; 115 (5): 2045–2108. doi: 10.1021/cr500279h.

38. Palecek E, Bartosik M. Electrochemistry of nucleic acids. Chem Rev 2012; 112 (6): 3427–3481. doi: 10.1021/cr200303p.

39. Bartosik M, Palecek E, Vojtesek B. Elektrochemická analýza nukleových kyselin, bílkovin a polysacharidů v biomedicíně. Klin Onkol 2014; 27 (Suppl 1): S53–S60.

40. Campuzano S, Pedrero M, Pingarron JM. Electrochemical genosensors for the detection of cancer-related miRNAs. Anal Bioanal Chem 2014; 406 (1): 27–33. doi: 10.1007/s00216-013-7459-z.

41. Boon EM, Salas JE, Barton JK. An electrical probe of protein-DNA interactions on DNA-modified surfaces. Nat Biotechnol 2002; 20 (3): 282–286.

42. Bartosik M, Koubkova L, Karban J et al. Electrochemical analysis of a novel ferrocene derivative as a potential antitumor drug. Analyst 2015; 140 (17): 5864–5867. doi: 10.1039/c5an00958h.

43. Wang P, Han P, Dong L et al. Direct potential resolution and simultaneous detection of cytosine and 5-methylcytosine based on the construction of polypyrrole functionalized graphene nanowall interface. Electrochem Commun 2015; 61: 36–39.

44. Deng H, Yang X, Yeo SP et al. Highly sensitive electrochemical methyltransferase activity assay. Anal Chem 2014; 86 (4): 2117–2123. doi: 10.1021/ac403716g.

45. Furst AL, Barton JK. DNA electrochemistry shows DNMT1 methyltransferase hyperactivity in colorectal tumors. Chem Biol 2015; 22 (7): 938–945. doi: 10.1016/j.chembiol.2015.05.019.

46. Furst AL, Muren NB, Hill MG et al. Label-free electrochemical detection of human methyltransferase from tumors. Proc Natl Acad Sci U S A 2014; 111 (42): 14985–14989. doi: 10.1073/pnas.1417351111.

47. Li W, Liu X, Hou T et al. Ultrasensitive homogeneous electrochemical strategy for DNA methyltransferase activity assay based on autonomous exonuclease III-assisted isothermal cycling signal amplification. Biosens Bioelectron 2015; 70: 304–309. doi: 10.1016/j.bios.2015.03.060.

48. Muren NB, Barton JK. Electrochemical assay for the signal-on detection of human DNA methyltransferase activity. J Am Chem Soc 2013; 135 (44): 16632–16640.

49. Wu H, Liu S, Jiang J et al. A sensitive electrochemical biosensor for detection of DNA methyltransferase activity by combining DNA methylation-sensitive cleavage and terminal transferase-mediated extension. Chem Commun 2012; 48 (50): 6280–6282. doi: 10.1039/c2cc32397d.

50. Zhang L, Wei M, Gao C et al. Label-free electrochemical detection of methyltransferase activity and inhibitor screening based on endonuclease HpaII and the deposition of polyaniline. Biosens Bioelectron 2015; 73: 188–194. doi: 10.1016/j.bios.2015.05.066.

51. Sina AA, Howell S, Carrascosa LG et al. eMethylsorb: electrochemical quantification of DNA methylation at CpG resolution using DNA-gold affinity interactions. Chem Commun (Camb) 2014; 50 (86): 13153–13156. doi: 10.1039/c4cc06732k.

52. Koo KM, Sina AA, Carrascosa LG et al. eMethylsorb: rapid quantification of DNA methylation in cancer cells on screen-printed gold electrodes. Analyst 2014; 139 (23): 6178–6184. doi: 10.1039/c4an01641f.

53. Wang P, Wu H, Dai Z et al. Picomolar level profiling of the methylation status of the p53 tumor suppressor gene by a label-free electrochemical biosensor. Chem Commun 2012; 48 (87): 10754–10756. doi: 10.1039/c2cc35 615e.

54. Bartosik M, Fojta M, Palecek E. Electrochemical detection of 5-methylcytosine in bisulfite-treated DNA. Electrochim Acta 2012; 78: 75–81.

55. [homepage on the Internet]. Společnost Epigenomics [updated 2016 May 16; cited 2016 May 16]. Available from: products-services/epi-procolon.html.

Paediatric clinical oncology Surgery Clinical oncology

Article was published in

Clinical Oncology

Issue Supplementum 4

2016 Issue Supplementum 4

Most read in this issue

This topic is also in:

Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.


Don‘t have an account?  Create new account